Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Phathom Pharmaceuticals (PHAT) Accumulated Depreciation & Amortization: 2022-2024

Historic Accumulated Depreciation & Amortization for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Dec 2024 value amounting to $200,000.

  • Phathom Pharmaceuticals' Accumulated Depreciation & Amortization changed negligibly% to $200,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $800,000, marking a year-over-year increase of 60.00%. This contributed to the annual value of $800,000 for FY2024, which is 33.33% up from last year.
  • As of Q4 2024, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization stood at $200,000, which was down 0.00% from $200,000 recorded in Q3 2024.
  • Over the past 5 years, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $1.5 million during Q4 2022, and registered a low of $100,000 during Q1 2023.
  • Its 3-year average for Accumulated Depreciation & Amortization is $515,333, with a median of $200,000 in 2024.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Accumulated Depreciation & Amortization tumbled by 92.33% in 2023 and then surged by 100.00% in 2024.
  • Phathom Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $1.5 million in 2022, then plummeted by 86.40% to $200,000 in 2023, then remained steady at $200,000 in 2024.
  • Its Accumulated Depreciation & Amortization stands at $200,000 for Q4 2024, versus $200,000 for Q3 2024 and $200,000 for Q2 2024.